Skip to main content
NVDA-0.70%AAPL+0.73%GOOGL-2.28%MSFT-0.17%AMZN+0.02%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.66%TSLA-1.32%SKHY+7.05%MU-1.81%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.22%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.34%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.59%AUDJPY-1.51%USDJPY-1.35%EURJPY-1.30%GBPJPY-1.24%CADJPY-1.21%NZDCAD-0.99%GBPNZD+0.94%EURNZD+0.92%NZDUSD-0.86%AUDNZD+0.70%USDNOK+0.65%NZDCHF-0.63%USDZAR+0.53%EURNOK+0.53%CHFNOK+0.46%USDSEK+0.42%EURZAR+0.41%GBPTRY+0.41%GBPZAR+0.40%CADCHF+0.36%AUDCAD-0.33%GBPCHF+0.33%GBPHKD+0.32%EURSEK+0.29%AUDNOK+0.29%GBPMXN-0.28%EURCHF+0.28%USDTHB+0.28%NOKJPY-0.27%USDPLN+0.25%GBPAUD+0.25%USDCHF+0.25%AUDDKK-0.24%SGDJPY+0.24%CHFSEK+0.22%USDMXN+0.22%AUDSGD-0.22%EURAUD+0.21%AUDUSD-0.16%USDILS+0.16%USDSGD+0.15%EURHKD-0.14%PLNJPY+0.13%USDCAD-0.13%USDDKK+0.13%EURPLN+0.12%USDTRY+0.11%GBPUSD+0.10%EURCAD-0.10%EURCNH-0.08%AUDCHF+0.08%EURCZK-0.08%NZDMXN+0.07%GBPCAD-0.05%CHFSGD-0.04%EURUSD+0.04%EURGBP-0.04%USDCOP-0.04%EURSGD+0.03%USDCNH+0.02%NZDSGD+0.02%GBPSGD+0.02%USDHKD+0.01%EURDKK0.00%HG1-4.16%XPTUSD-3.63%XAGUSD-2.51%GAGUSD-2.51%COFFEE-2.48%SUGAR+1.85%USOIL+1.66%UKOIL+1.57%COTTON+0.98%S1+0.73%COCOA-0.72%C1+0.71%BTCUSD-0.58%ETHUSD-0.24%USDTUSD-0.06%XRPUSD-1.26%SOLUSD-0.43%TRXUSDT+0.50%ZECUSDT-1.89%DOGEUSD-1.09%XMRUSDT-1.13%LINKUSD+0.26%XLMUSD-0.97%BCHUSDT-2.60%LTCUSD-1.77%UNIUSD-2.02%TONUSD+24.88%HBARUSDT-1.05%SUIUSD-1.33%TAOUSDT-1.05%AAVEUSD-2.18%DOTUSDT-2.01%ICPUSDT-1.15%ONDOUSDT-1.98%WLDUSDT-1.47%ATOMUSDT-2.97%ARBUSDT-0.97%JUPUSDT-2.53%INJUSDT-2.13%STXUSDT-2.34%FETUSDT-2.59%TIAUSDT-0.08%PYTHUSDT-0.42%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.83%OPUSDT-0.99%POLUSDT-5.19%IOTAUSDT-2.94%AXSUSDT-1.82%FARTCOINUSDT-2.72%EOSUSDT-0.06%DYDXUSDT+1.06%ORDIUSDT-0.16%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.70%AAPL+0.73%GOOGL-2.28%MSFT-0.17%AMZN+0.02%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.66%TSLA-1.32%SKHY+7.05%MU-1.81%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.22%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.34%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.59%AUDJPY-1.51%USDJPY-1.35%EURJPY-1.30%GBPJPY-1.24%CADJPY-1.21%NZDCAD-0.99%GBPNZD+0.94%EURNZD+0.92%NZDUSD-0.86%AUDNZD+0.70%USDNOK+0.65%NZDCHF-0.63%USDZAR+0.53%EURNOK+0.53%CHFNOK+0.46%USDSEK+0.42%EURZAR+0.41%GBPTRY+0.41%GBPZAR+0.40%CADCHF+0.36%AUDCAD-0.33%GBPCHF+0.33%GBPHKD+0.32%EURSEK+0.29%AUDNOK+0.29%GBPMXN-0.28%EURCHF+0.28%USDTHB+0.28%NOKJPY-0.27%USDPLN+0.25%GBPAUD+0.25%USDCHF+0.25%AUDDKK-0.24%SGDJPY+0.24%CHFSEK+0.22%USDMXN+0.22%AUDSGD-0.22%EURAUD+0.21%AUDUSD-0.16%USDILS+0.16%USDSGD+0.15%EURHKD-0.14%PLNJPY+0.13%USDCAD-0.13%USDDKK+0.13%EURPLN+0.12%USDTRY+0.11%GBPUSD+0.10%EURCAD-0.10%EURCNH-0.08%AUDCHF+0.08%EURCZK-0.08%NZDMXN+0.07%GBPCAD-0.05%CHFSGD-0.04%EURUSD+0.04%EURGBP-0.04%USDCOP-0.04%EURSGD+0.03%USDCNH+0.02%NZDSGD+0.02%GBPSGD+0.02%USDHKD+0.01%EURDKK0.00%HG1-4.16%XPTUSD-3.63%XAGUSD-2.51%GAGUSD-2.51%COFFEE-2.48%SUGAR+1.85%USOIL+1.66%UKOIL+1.57%COTTON+0.98%S1+0.73%COCOA-0.72%C1+0.71%BTCUSD-0.58%ETHUSD-0.24%USDTUSD-0.06%XRPUSD-1.26%SOLUSD-0.43%TRXUSDT+0.50%ZECUSDT-1.89%DOGEUSD-1.09%XMRUSDT-1.13%LINKUSD+0.26%XLMUSD-0.97%BCHUSDT-2.60%LTCUSD-1.77%UNIUSD-2.02%TONUSD+24.88%HBARUSDT-1.05%SUIUSD-1.33%TAOUSDT-1.05%AAVEUSD-2.18%DOTUSDT-2.01%ICPUSDT-1.15%ONDOUSDT-1.98%WLDUSDT-1.47%ATOMUSDT-2.97%ARBUSDT-0.97%JUPUSDT-2.53%INJUSDT-2.13%STXUSDT-2.34%FETUSDT-2.59%TIAUSDT-0.08%PYTHUSDT-0.42%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.83%OPUSDT-0.99%POLUSDT-5.19%IOTAUSDT-2.94%AXSUSDT-1.82%FARTCOINUSDT-2.72%EOSUSDT-0.06%DYDXUSDT+1.06%ORDIUSDT-0.16%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
BB

Beta Bionics, Inc. (BBNX)

NASDAQ • Healthcare

$17.42
-$1.9 (-9.9%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$19.14
Day Range$17.26 - $19.54
Avg. Volume (3M)1M
Market Cap$783.7M
52 Week Range
$8.8$32.71
Next EarningsIn 47 daysOct 27, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$32M100%
Gross Profitminus cost of goods$18.9M59%

In plain terms: out of every $100 in revenue, Beta Bionics, Inc. currently loses $73.

Fundamentals & Financials

Revenue (TTM)
$119M
Net Income (TTM)
-$72.9M
EPS (TTM)
-$1.68
ROA (TTM)
-24.96%
Current Ratio
8.88

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+28.6%Q1 2026-$0.3
+7.5%Q2 2026-$0.49
+8.8%Q3 2026-$0.53
Next

Oct 27

in 47 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +8.8%

Beta Bionics beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported July 29, 2026, as revenue rose 37.8% to about $32.0 million, driven by its insulin-delivery systems lineup led by the iLet Bionic Pancreas platform. Revenue of $32.0 million topped the $31.5 million estimate, +2%, while EPS of -$0.53 topped the -$0.58 estimate by $0.05 (down from -$0.39 a year ago). Profitability tracked higher gross margin but remained loss-making at the operating line, with gross profit of roughly $18.9 million and gross margin at 59.0% alongside an operating loss of about $25.6 million and operating margin of -79.9%. Net income was -$23.4 million (down from -$16.9 million a year ago, -38.7%), and operating cash flow was negative at roughly $14.6 million. For the next period, consensus calls for EPS of -$0.55 on revenue of $35.0 million.

View full earnings history

About Beta Bionics, Inc.

Beta Bionics, Inc. develops insulin-delivery systems for people with diabetes who depend on insulin and trades on the NASDAQ under BBNX as a medical-device company in healthcare. Its products center on automated dosing platforms, and the company generated $100.3 million of revenue in FY2025.

Name
Beta Bionics, Inc.
CEO
Sean T. Saint
Website
www.betabionics.com
Industry
Healthcare
Year Founded
2015
Employees
422

Today's Snapshot

AI-generated

BBNX closed 9.9% below yesterday's close, while its sector was flat. Beta Bionics was sued by investors alleging it misled them about its medical device’s safety.

Trading Volume

Above 10d avg 824.4K

848K

vs S&P 500 Today

Strong Underperformance

-9.46%

Updated: September 9, 2026 at 20:15 UTC

Technical Indicators

2 Buy3 Neutral3 Sell
BBNX is priced near 17.42 and currently trades beneath its short-term moving averages and the pivot level, even as the 50- and 100-day averages sit closer to the current price, creating a mixed moving-average picture. Momentum readings are tepid rather than bullish, and the stock’s on-balance volume is negative, suggesting distribution despite a strong ADX that points to a persistent directional trend. Volatility is elevated for the share level, which can amplify downside moves while short-term indicators fail to show clear support. Technical takeaway: Sell — momentum weak, negative volume and price under key short-term averages.
All signals
  • EMA (5 indicators)$16.21 - $19.01
    Sell
  • RSI (14)44.38
    Neutral
  • Stochastic %K (14, 3, 3)33.07
    Neutral
  • MACD Level (12, 26)0.64
    Neutral

Peers & Related Assets

PLSEPulse Biosciences, Inc.
$52.97+8.6%
PGENPrecigen, Inc.
$6.8-1.0%
KMTSKestra Medical Technologies, Ltd.
$24.07-6.1%
ORICORIC Pharmaceuticals, Inc.
$12.5-0.9%
STAASTAAR Surgical Company
$23.62-2.2%
AHCOAdaptHealth Corp.
$5.7-7.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.